Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM106C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COL2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927180 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PFKM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC48A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on